SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is facing a severe sell-off following the collapse of a key relationship with Marvell, which terminated purchase orders citing a confidentiality breach by management. The community is sharply divided between investors calling for a total leadership overhaul due to the perceived communication failures and those attempting to justify the drop as an overreaction that creates a long-term buying opportunity.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science SA is experiencing significant retail interest and extreme volatility, with the community actively speculating about a short squeeze due to its extremely low float. Investors are heavily focused on the company's recent molecular farming breakthroughs and the consolidation of ownership, leading to intense debate regarding whether the stock is a long-term value play or a high-risk momentum trade prone to dramatic price swings.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as it breaks into new all-time high territory, with the community largely focused on the stock's massive institutional momentum and its role as the centerpiece of the ongoing AI infrastructure supercycle. While many investors are celebrating the breakout and discussing aggressive new price targets, others are debating the sustainability of the rally, noting potential divergences in market breadth and questioning the long-term impact of extreme valuations.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors monitor high short interest and limited share availability, which supporters believe sets the stage for a significant short squeeze. Sentiment is bolstered by the pending Northern Data acquisition and strategic partnerships with Tether, leading the community to discuss its potential as a long-term AI and cloud infrastructure play.

Dumb SEND IT

Dumb SEND IT ($DSIT) is gaining momentum as a community-driven low-cap project where active holders are pushing to reach aggressive market milestones while the developer engages users through planned airdrops and social interaction. Community sentiment remains focused on the potential for a 'weekend runner' breakout, with supporters emphasizing the importance of holding through volatility to reach higher valuations.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond is trending as investors react to the company's recent quarterly earnings report, which showcased its first revenue growth in nearly five years and aggressive cost-cutting measures. While the community is actively debating the viability of the turnaround strategy and comparing the stock's volatile price action to previous meme-stock cycles, sentiment remains sharply divided between those optimistic about the new leadership's vision and skeptics pointing to the firm's history of financial instability.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to successful demonstration flights in New York City and ongoing FAA certification progress, signaling a shift from concept to real-world deployment. While the community is actively debating the stock's long-term execution risk and potential for volatility, many see the recent milestones as a critical step toward the company's 2026 commercial launch goals.

High-Trend International Group is a holding company. It engages in shipping decarbonization and carbon asset management platforms. The company was founded in 2021 and is headquartered in Singapore.

High-Trend International Group. - Ordinary Shares - Class A

High-Trend International Group is experiencing extreme volatility and intense community speculation following a parabolic run that has driven significant short-squeeze discussions. Investors are actively debating the sustainability of this momentum, with many highlighting the stock's low float and the ongoing battle between aggressive buying and short-selling interest.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Edesa Biotech is experiencing significant volatility and trading volume as investors react to bullish institutional accumulation and ongoing speculation regarding potential buyout interest or strategic partnerships for its lead asset, paridiprubart. Community discussions remain polarized between optimistic longs betting on a major acquisition or regulatory breakthrough and vocal skeptics highlighting historical trial delays and the potential for share dilution.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is currently trending as investors weigh recent partnership news with Neura Robotics against broader semiconductor headwinds, including potential market share losses and memory supply constraints. Community sentiment is deeply divided, with many traders discussing the stock's significant undervaluation relative to its AI, automotive, and edge-computing growth prospects, while skeptics emphasize concerns over long-term handset dependency and sluggish price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Rating Lowered to Hold at Wall Street Zen

Wall Street Zen lowered Kiniksa Pharmaceuticals International from a "buy" rating to a "hold" rating in a report on Sunday...

Kiniksa Pharmaceuticals International (KNSA) to Release Earnings on Tuesday

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) will be releasing its Q1 2026 earnings before the market opens on Tuesday, April 28. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-28-kiniksa-pharmaceuticals-ltd-stock...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Trading Down 4.3% - Here's What Happened

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Down 4.3% - Here's What Happened...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded by Wall Street Zen to "Buy" Rating

Wall Street Zen upgraded shares of Kiniksa Pharmaceuticals International from a "hold" rating to a "buy" rating in a report on Saturday...

What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge

Key PointsThe chief accounting officer of Kiniksa Pharmaceuticals sold 6,625 shares for roughly $309,000 on April 9, 2026...

Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lowered its stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 7.2% in the fourth quarter, according to its most...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Price Target Raised to $58.00 at Wedbush

Wedbush lifted their price objective on shares of Kiniksa Pharmaceuticals International from $53.00 to $58.00 and gave the company an "outperform" rating in a research report on Thursday...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $79,513.07 in Stock

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) COO Ross Moat sold 1,703 shares of the business's stock in a transaction that occurred on Thursday, April 9th. The stock was sold at an average price of $46.69, for a total value of $79,513.07. Following the completion of...

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Sells 6,625 Shares of Stock

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) CAO Michael Megna sold 6,625 shares of the business's stock in a transaction that occurred on Thursday, April 9th. The shares were sold at an average price of $46.69, for a total transaction of $309,321.25. Following the...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Ross Moat Sells 1,703 Shares

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) COO Ross Moat sold 1,703 shares of the firm's stock in a transaction on Thursday, April 9th. The shares were sold at an average price of $46.69, for a total transaction of $79,513.07. Following the sale, the chief operating...

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Current Price	$43.61
Prev Close	$42.79
Open	$42.67
Dividend Yield	0.00%
50-Day Moving Average	$45.89
Beta	0.69
Avg. Volume	675,062.87
PE Ratio	57.41

52-Week High	$50.03
52-Week Low	$21.25
Market Capitalization	$3.27B
EPS (Annual)	$0.7471
Price to Book	5.75
Revenue Per Employee	$1.85M

KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KNSA News

KNSAKiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A